Other
Deprescribing
Deprescribing is an intervention with 3 clinical trials. Currently 1 active trials ongoing. Historical success rate of 100.0%.
Total Trials
3
Max Phase
—
Type
OTHER
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 2 completed trials
Completion Rate
100%(2/2)
Active Trials
1(33%)
Results Posted
50%(1 trials)
Phase Distribution
Ph not_applicable
3
100%
Phase Distribution
0
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution3 total trials
N/ANon-phased studies
3(100.0%)
Highest Phase Reached
UnknownTrial Status & Enrollment
Completion Rate
100.0%
2 of 2 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
1
trials recruiting
Total Trials
3
all time
Status Distribution
Active(1)
Completed(2)
Detailed Status
Completed2
Recruiting1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
1
Success Rate
100.0%
Most Advanced
N/A
Trials by Phase
N/A3 (100.0%)
Trials by Status
recruiting133%
completed267%
Recent Activity
1 active trials
Showing 3 of 3
completednot_applicable
Augmenting Benzodiazepine Receptor Agonist Deprescribing With Acupuncture and Yoga Among Older Adults
NCT06197243
recruitingnot_applicable
Deprescribing Intervention for Patients With Chronic Kidney Disease
NCT06324045
completednot_applicable
Reducing Use of Sleep Medications Assisted by a Digital Insomnia Intervention
NCT05027438
Clinical Trials (3)
Showing 3 of 3 trials
NCT06197243Not Applicable
Augmenting Benzodiazepine Receptor Agonist Deprescribing With Acupuncture and Yoga Among Older Adults
NCT06324045Not Applicable
Deprescribing Intervention for Patients With Chronic Kidney Disease
NCT05027438Not Applicable
Reducing Use of Sleep Medications Assisted by a Digital Insomnia Intervention
All 3 trials loaded
Drug Details
- Intervention Type
- OTHER
- Total Trials
- 3